DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Passweg JR, Baldomero H, Basak GW. et al.
The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies.
Bone Marrow Transpl 2019;
DOI: 10.1038/s41409-019-0465-9.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.